An observational study in Perioperative/Postoperative Complications, sponsored by Atatürk Chest Diseases and Chest Surgery Training and Research Hospital. Completed at 1 site in Turkey. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2022-02-16.
Sponsored by Atatürk Chest Diseases and Chest Surgery Training and Research Hospital · Observational
Postoperative pulmonary complications (PPC) emerge as a major risk that determines the morbidity and mortality of patients after surgery. PPCs affect the length of hospital stay and increase health costs. Because of this reason, it is important to predict PPCs before surgery. There are many studies on scoring systems that can be effective in predicting PPCs. The most frequently used ones are the Assess Respiratory Risk in Surgical Patients in Catalonia (ARISCAT) risk index, the Nutritional Risk Score (NRS), and the American Society of Anesthesiologist (ASA) score. ARISCAT risk index is mostly evaluated in operations performed other than thoracic surgery. Since the thoracic wall, mediastinum or lungs are directly intervened in thoracic surgery operations, the expected PPCs in these patients may be different from those expected in other surgical groups. Therefore, the ARISCAT risk index may be insufficient to evaluate PPCs in thoracic surgery.
1,233 studies on the registry are indexed under Postoperative Complications; 292 are open to participants now.
This study's enrollment of 130 is below the median of 254 across 519 observational studies indexed under Postoperative Complications.
Browse Postoperative Complications studies →Atatürk Chest Diseases and Chest Surgery Training and Research Hospital is the lead sponsor of 28 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients aged 18-75 years who are scheduled for elective thoracotomy or VATS, who have not had previous thoracic surgery, and without advanced lung and heart disease.
Exclusion Criteria:
Neutrophil/ Lymphocite ratio, albumin level and scoring systems has been evaluated.
Distribution of patients who developed one or more postoperative pulmonary complications according to preoperative neutrophil/lymphocyte ratio, albumin value, ARISCAT risk index, nutritional risk score, and ASA physical status.
1. Effectiveness of the ARISCAT risk scoring index \[ Time Frame: postoperative first 30 days \] to investigate the effectiveness of the ARISCAT risk scoring index in predicting the development of PPC in patients undergoing thoracic surgery. 2. Correlation between ASA physical status (1-3) and PPC \[ Time Frame: postoperative first 30 days \] 3. Correlation between NRS ( nutritional risk score) score (0-3) and PPC \[ Time Frame: postoperative first 30 days \] 4. Correlation between preoperative albumin values (gram / dl) and PPC \[ Time Frame: postoperative first 30 days \] 5. Correlation between preoperative neutrophil/lymphocyte ratio and PPC \[ Time Frame: postoperative first 30 days \]
Time frame: Time to preoperative visit and through study completion, an average of three months.
Distribution of patients who developed one or more postoperative pulmonary complications according to age, gender, BMI and preoperative SpO2 level.
1. Correlation between age (years) and PPC \[ Time Frame: postoperative first 30 days 2. Correlation between gender(male or female) and PPC \[ Time Frame: postoperative first 30 days \] 3. Correlation between BMI (kg/m\^2) and PPC \[ Time Frame: postoperative first 30 days \] 4. Correlation between Preoperative Sp02(\>96%, 91%-95%, \<90%) and PPC \[ Time Frame: postoperative first 30 days \]
Time frame: Time to preoperative visit and up to 30 days.
Plan to share: No
This study is completed, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital